• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 425 filed by BlueRiver Acquisition Corp.

    8/6/24 4:54:23 PM ET
    $BLUA
    Blank Checks
    Finance
    Get the next $BLUA alert in real time by email
    425 1 ea0210734-8k425_blue.htm CURRENT REPORT

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): August 2, 2024

     

     

     

    BlueRiver Acquisition Corp.

    (Exact name of registrant as specified in its charter)

     

     

     

    Cayman Islands   001-39961   98-1577027

    (State or other jurisdiction of

    incorporation or organization)

      (Commission File Number)  

    (I.R.S. Employer

    Identification Number)

     

    250 West Nottingham Drive, Suite 400

    San Antonio, Texas

      78209
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (210) 832 3305

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one Class A ordinary share and one-third of a redeemable Warrant to acquire one Class A ordinary share   BLUA.U    
    Class A ordinary share, par value $0.0001 per share   BLUA    
    Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   BLUA.WS    

      

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    The information included in Item 5.07 is incorporated by reference in this item to the extent required.

     

    Item 5.07 Submission of Matters to a Vote of Security Holdings.

     

    The Company held the extraordinary general meeting (the “Extraordinary General Meeting”) at 12:00 p.m. Eastern Time on August 2, 2024 for the purposes of considering and voting upon:

     

    ●The Extension Proposal – to consider and vote upon a proposal by the following special resolution to amend the Company’s amended and restated memorandum and articles of association (the “Existing Charter”) to allow the board of directors of the Company (the “Board”), without another shareholder vote, to elect to extend the date by which, if the Company has not consummated a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company, with one or more businesses or entities (a “Business Combination”), the Company must (a) cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Class A ordinary shares sold in the Company’s initial public offering (the “Public Shares”); and (c) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law, from August 2, 2024 (the “Original Termination Date”) to up to 4 times by an additional 3 months each time after the Original Termination Date, by resolution of the Board, until August 2, 2025 (each, an “Additional Charter Extension Date”) or a total of up to 12 months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Extension”, such extension deadline, the “Extended Date”, and such proposal, the “Extension Proposal”).

     

    ●The Adjournment Proposal — to consider and vote upon a proposal (the “Adjournment Proposal”) by the following ordinary resolution to approve the adjournment of the Extraordinary General Meeting by the chair thereof to a later date, if necessary, under certain circumstances, to solicit additional proxies for the purpose of approving the Extension Proposal, to amend the Extension Proposal, or to allow reasonable additional time for the filing or mailing of any supplemental or amended disclosure that the Company has determined in good faith after consultation with outside legal counsel is required under applicable law and for such supplemental or amended disclosure to be disseminated and reviewed by the Company’s shareholders prior to the Extraordinary General Meeting; provided that the Extraordinary General Meeting is reconvened as promptly as practical thereafter. The Adjournment Proposal will only be presented at the Extraordinary General Meeting if there are not sufficient votes to approve the Extension Proposal.

     

    For more information on these proposals, please refer to the Company’s proxy statement dated July 15, 2024 (as amended or supplemented, the “Proxy Statement”). As of the record date of June 20, 2024, there were a total of 9,555,210 ordinary shares issued and outstanding and entitled to vote at the Extraordinary General Meeting. Proxies were received for 8,488,193 ordinary shares, or approximately 88.83% of the shares issued and outstanding and entitled to vote at the Extraordinary General Meeting; therefore a quorum was present.

     

    Shareholders voted to approve the Extension Proposal. The proposal received the following final voting results:

     

    For  Against   Abstain 
    8,353,645   134,548    0 

     

    The Adjournment Proposal was not presented to the shareholders because there were sufficient votes to approve the Extension Proposal.

     

    A copy of the Amendment of the Company’s Amended and Restated Memorandum and Articles of Association as adopted on August 2, 2024 by special resolution of the shareholders is attached to this Current Report on Form 8-K as Exhibit 3.1 and is incorporated herein by reference.

     

    Item 9.01 Financial Statements and Exhibits.

     

      (d) Exhibits.

     

    Exhibit   Description
    3.1   Amendment to the Amended and Restated Memorandum and Articles of Association of BlueRiver Acquisition Corp.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    BlueRiver Acquisition Corp.  
         
    By:

    /s/ John Gregg

     
    Name: John Gregg  
    Title: Co-Chief Executive Officer  

     

    Dated: August 6, 2024

     

    2

     

     

    Get the next $BLUA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLUA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLUA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NYSE American to Suspend Trading in BlueRiver Acquisition Corp. (BLUA)

      NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares (NYSE:BLUA) and units (NYSE:BLUA) of BlueRiver Acquisition Corp. (the "Company") from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company's listed securities, which included Company's Class A ordinary shares, units and redeemable warrants (collectively, "Securities"), and the Company appealed such delisting determination. On July 3, 2024, the NYSE American suspended trading in the Company's redeemable warrants as they were trading at an a

      7/15/24 9:15:00 AM ET
      $BLUA
      Blank Checks
      Finance
    • BlueRiver Acquisition Corp. Receives Commencement of Delisting Notice From NYSE American; Announces Extension of Merger Agreement

      BlueRiver Acquisition Corp. (NYSE:BLUA) (the "Company") announces that, as disclosed in the Company's Current Report on Form 8-K filed on February 7, 2024 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC ("NYSE American" or the "Exchange") on February 2, 2024, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company's Common Stock, Units and Rights (collectively, the "Securities") pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offe

      2/7/24 5:58:00 PM ET
      $BLUA
      Blank Checks
      Finance
    • Spinal Stabilization Technologies, LLC, a Leading Developer and Manufacturer of Spinal Medical Devices, to be Publicly Listed through a Proposed Business Combination with BlueRiver Acquisition Corp.

      Spinal Stabilization Technologies is a pioneer in developing minimally invasive surgical treatments for specific types of lower back pain. It is targeting a promising market opportunity within the areas of Augmented Discectomy and Degenerative Disc Disease. In March 2021, the FDA granted the PerQdisc Nucleus Replacement System, the Company's leading product candidate, designation as a Breakthrough Device, potentially allowing for a more streamlined FDA review process and reduced regulatory costs. Proposed transaction represents a pre-money equity value of $240 million for Spinal Stabilization Technologies. Existing Spinal Stabilization Technologies shareholders will roll 100% o

      7/24/23 5:04:00 AM ET
      $BLUA
      Blank Checks
      Finance

    $BLUA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by BlueRiver Acquisition Corp.

      SC 13G/A - BlueRiver Acquisition Corp. (0001831006) (Subject)

      8/9/24 2:47:16 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by BlueRiver Acquisition Corp. (Amendment)

      SC 13G/A - BlueRiver Acquisition Corp. (0001831006) (Subject)

      5/10/24 4:21:54 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form SC 13G filed by BlueRiver Acquisition Corp.

      SC 13G - BlueRiver Acquisition Corp. (0001831006) (Subject)

      3/11/24 7:49:12 PM ET
      $BLUA
      Blank Checks
      Finance

    $BLUA
    SEC Filings

    See more
    • SEC Form 425 filed by BlueRiver Acquisition Corp.

      425 - BlueRiver Acquisition Corp. (0001831006) (Subject)

      8/6/24 4:54:23 PM ET
      $BLUA
      Blank Checks
      Finance
    • BlueRiver Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - BlueRiver Acquisition Corp. (0001831006) (Filer)

      8/6/24 4:51:44 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form DEF 14A filed by BlueRiver Acquisition Corp.

      DEF 14A - BlueRiver Acquisition Corp. (0001831006) (Filer)

      7/26/24 4:36:22 PM ET
      $BLUA
      Blank Checks
      Finance